Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

HMGB1 restricts EPO signaling, contributing to anemia of inflammation

Feb. 2, 2022

MAP3K7 modulation to treat MDS-associated anemia

Jan. 10, 2022

Hematologic

Jan. 1, 2022

Emendo Biotherapeutics develops CRISPR-based ex-vivo gene editing strategy for ELANE neutropenia

Dec. 29, 2021

Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders

Dec. 17, 2021

Generation Bio reports progress in hemophilia A program

Dec. 15, 2021

ASP-8731 inhibits microvascular stasis in models of sickle cell disease

Dec. 15, 2021

CRISPRa-mediated SEC23A activation rescues SEC23B-deficient CDAII in vivo

Dec. 3, 2021

Merck & Co. divulges coagulation factor XIa inhibitors

Dec. 3, 2021

Janssen publishes PK/PD data for the anticoagulant-reversing agent JNJ-67842125

Nov. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...